-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
EyePoint Pharmaceuticals, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q3 2017 to Q2 2024.
- EyePoint Pharmaceuticals, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $50K, a 99.1% decline year-over-year.
- EyePoint Pharmaceuticals, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $6.71M, a 70.8% decline year-over-year.
- EyePoint Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2023 was $11.7M, a 54.2% decline from 2022.
- EyePoint Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2022 was $25.5M, a 7.26% decline from 2021.
- EyePoint Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2021 was $27.5M, a 8.74% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)